Background The Toronto stentless porcine valve (SPV) was designed to i
mprove hemodynamics after aortic valve replacement by maximizing avail
able flow area in comparison to stented valves (STD). Methods To asses
s possible hemodynamic differences between STD and SPV, 59 patients un
dergoing isolated aortic valve replacement (+/- coronary artery bypass
graft) were prospectively evaluated by preoperative and 3- to 6-month
postoperative echocardiography. Among these, 23 patients received a S
TD, whereas 36 received the Toronto SPV. Results The mean size (mm) of
SPV implanted was larger (SPV, 26.6 +/- 2.1; STD, 24.0 +/- 2.9; P=0.0
002). Patients receiving STD valves were older and had a higher preval
ence of coronary artery disease and congestive heart failure. There we
re no preoperative differences in left ventricular mass index (g/mo(2)
), peak or mean pressure gradients (mmHg), effective orifice area (cm(
2)), extent of fractional shortening (%), or velocity of circumferenti
al shortening (cf/sec). ANOVA demonstrated a significant reduction in
left ventricular mass index at 3 to 6 months (P=.0001) but no differen
ces in left ventricular mass index regression between groups (STD, -28
.8 +/- 37.5; SPV, -31.2 +/- 32.4; P=.36). Effective orafice area was i
ncreased postoperatively (P=.0001), particularly among SPV cases (STD,
1.5 +/- 0.4; SPV, 1.9 +/- 0.7; P=.01). Postoperative left ventricular
mass index and mean pressure gradient were reduced (P=.0001) but did
not differ between groups. Fractional shortening and velocity of circu
mferential shortening were greater in the SPV patients at 3 to 6 month
s after aortic valve replacement (P=.0004 and .0001, respectively), an
d an interactive effect was seen between time and prosthetic group (P=
.0028 and .032, respectively). Conclusions In a consecutive series of
patients, we identified no hemodynamic differences between STD and SPV
, although ventricular function improved after SPV. Because of the non
randomized nature of the study, selection bias may have accounted for
some of the observed results. A prospective, randomized trial is neces
sary to determine the hemodynamic advantages, if any, of the SPV valve
.